Trials
First presentations of major trials results
![ALBICS-AKI trial logo](/templates/yootheme/cache/ff/ALBICS_AKI_Logo_400_transparent-ffa881bf.png)
ALBICS-AKI
Postoperative 20% albumin vs standard care and acute kidney injury after high-risk cardiac surgery
![](https://criticalcarereviews.com/images/Meetings/CCR24-DU/Trial%20Logos/SAHaRA_400.png)
SAHARA
Aneurysmal SubArachnoid Hemorrhage-Red Blood Cell Transfusion and Outcome Study
![](/templates/yootheme/cache/f0/Screen_messy_400-f0badd1a.png)
SCREEN
Electronic early notification of sepsis in hospitalized ward patients
![TRAUMOX2 Trial Logo](/templates/yootheme/cache/5c/TRAUMOX2_400-5c44afd1.png)
TRAUMOX2
Restrictive versus liberal oxygen strategies for trauma patients
Trial Registration | Protocol | SAP | Website
![RENOVATE Trial Logo](https://criticalcarereviews.com/images/Meetings/CCR24-DU/Trial%20Logos/RENOVATE_logo_400.png)
RENOVATE
High flow nasal catheter therapy versus non-invasive positive pressure ventilation in acute respiratory failure
![](/templates/yootheme/cache/77/VACARiSS_logo_400-771cbdcf.png)
VACIRiSS
Vaccination for immune recovery following sepsis:The VACIRiSS Trial
![](/templates/yootheme/cache/47/EVIDENCE_logo_400-47ab3718.png)
EVIDENCE
Efficacy and Value In ExpeDited out of hospital arrEst care with End tidal CO2, ECMO, & CPR
![](/templates/yootheme/cache/38/ADAPT-SEPSIS_ai_400-3875b01f.png)
ADAPT-Sepsis
biomArker-guided Duration of Antibiotic treatment in hospitalised Patients with suspecTed Sepsis